GNFT logo

Genfit SA (GNFT)

Profile

Full Name

Genfit S.A.

Ticker Symbol

GNFT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

March 27, 2019

Indexes

Not included

Website

http://www.genfit.com

Employees

169

Key Details

Price

$3.69(+6.50%)

Market cap

$183.91M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$30.92M(+45.20% YoY)

Annual EPS

-$0.63(-24.04% YoY)

PE ratio

-

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.69
GNFT price is $3.69

30-Day Relative Volume

0.47
GNFT 30-day relative volume is 0.47

Price Performance

Price Most recent change

+6.5%
GNFT price was up +6.5% on Apr 15, 2025

Price YTD change

-0.81%
GNFT price is down -0.81% since January 1st

Price 1-year change

+1.52%
GNFT price is up +1.52% year-on-year

Price 3-year change

-8.79%
GNFT price is down -8.79% over the past 3 years

Price Range

Price All-time high

$26.25
GNFT price is currently -85.96% below its historical high of $26.25

Price 3-year low

$2.55
GNFT price is currently +44.51% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$183.91M
GNFT market capitalization is $183.91 million

Market cap 3-year change

-8.62%
GNFT market capitalization is down -8.62% over the past 3 years

Market cap All-time high

$996.03M
GNFT market capitalization is currently -81.54% below its historical high of $996.03 million

Market cap sector rank

56%
GNFT market capitalization is higher than 56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.09%
GNFT shares outstanding is up +0.09% year-on-year

Shares Outstanding 3-Year Change

+0.18%
GNFT shares outstanding is up +0.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.67
GNFT beta is -0.67

200-day SMA

$4.24
GNFT price is currently -13.07% below its 200-day simple moving average

50-day SMA

$3.62
GNFT price is currently +1.92% above its 50-day simple moving average

RSI

55.23
GNFT 14-day relative strength index is 55.23

Volume

0.47
GNFT 30-day relative volume is 0.47

ATR

$0.20
GNFT average true range is $0.20

10-day Historical Volatility

158.32%
GNFT 10-day historical volatility is 158.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$30.92M
GNFT annual revenue is $30.92 million

Revenue Analysts estimate

$77.37M
GNFT annual revenue is currently -60.03% lower than the consensus analysts' forecast

Revenue 1-year change

+45.2%
GNFT annual revenue is up +45.2% year-on-year

Revenue Sector rank

39.55%
GNFT annual revenue is higher than 39.55% of companies in Healthcare sector

EPS

EPS

-$0.63
GNFT annual earnings per share is -$0.63

EPS Analysts estimate

$0.58
GNFT annual earnings per share is currently -208.26% lower than the consensus analysts' forecast

EPS 1-year change

-24.04%
GNFT annual earnings per share is down -24.04% year-on-year

EPS Sector rank

64.62%
GNFT annual earnings per share is higher than 64.62% of companies in Healthcare sector

Profit

Gross profit

$30.56M
GNFT annual gross profit is $30.56 million

Gross margin

98.81%
GNFT annual gross profit margin is 98.81%

Operating profit

-$29.41M
GNFT annual operating income is -$29.41 million

Operating margin

-95.10%
GNFT annual operating profit margin is -95.10%

Net income

-$31.28M
GNFT annual net profit is -$31.28 million

Net margin

-101.15%
GNFT annual net profit margin is -101.15%

Expenses

Total expenses

$60.33M
GNFT annual total expenses is $60.33 million

Operating expenses

$59.96M
GNFT annual total operating expenses is $59.96 million

Cost of goods sold

$369.20K
GNFT annual cost of goods sold is $369.20 thousand

Selling, general & administrative expenses

$8.71M
GNFT annual SGA is $8.71 million

Depreciation and amortization

$1.79M
GNFT annual depreciation & amortization is $1.79 million

Interest expense

$5.01M
GNFT annual interest expense is $5.01 million

Income tax

$411.40K
GNFT annual income tax is $411.40 thousand

EBIT & EBITDA

EBIT

-$25.86M
GNFT annual earnings before interest & taxes is -$25.86 million

EBITDA

-$24.07M
GNFT annual EBITDA is -$24.07 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$192.20M
GNFT annual total assets is $192.20 million

Non current assets

$67.16M
GNFT annual long term assets is $67.16 million

Current assets

$125.04M
GNFT annual total current assets is $125.04 million

Cash and cash equivalents

$85.99M
GNFT annual cash & cash equivalents is $85.99 million

Accounts receivable

$20.48M
GNFT annual accounts receivable is $20.48 million

Inventory

$4400.00
GNFT annual inventory is $4400.00

Liabilities

Total liabilities

$117.09M
GNFT annual total liabilities is $117.09 million

Long term liabilities

$74.55M
GNFT annual total long term liabilities is $74.55 million

Current liabilities

$42.54M
GNFT annual total current liabilities is $42.54 million

Accounts payable

$11.55M
GNFT annual accounts payable is $11.55 million

Debt

Total debt

$77.58M
GNFT annual total debt is $77.58 million

Total debt 1-year change

-3.9%
GNFT annual total debt is down -3.9% year-on-year

Long term debt

$68.81M
GNFT annual long term debt is $68.81 million

Short term debt

$8.76M
GNFT annual short term debt is $8.76 million

Equity & Capital

Shareholders equity

$75.11M
GNFT annual stockholders equity is $75.11 million

Book value

$75.11M
GNFT annual book value is $75.11 million

Retained earnings

-$431.95M
GNFT annual retained earnings is -$431.95 million

Working capital

$82.50M
GNFT annual working capital is $82.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.01M
GNFT annual cash flow from operations is -$60.01 million

Cash from operations 1-year change

+21.66%
GNFT annual cash flow from operations is up +21.66% year-on-year

Cash from investing

$2.42M
GNFT annual cash flow from investing activities is $2.42 million

Cash from investing 1-year change

+104.96%
GNFT annual cash flow from investing activities is up +104.96% year-on-year

Cash from financing

-$5.52M
GNFT annual cash flow from financing activities is -$5.52 million

Cash from financing 1-year change

-38.23%
GNFT annual cash flow from financing activities is down -38.23% year-on-year

CAPEX

CAPEX

$2.69M
GNFT annual capital expenditures is $2.69 million

CAPEX 1-year change

-
GNFT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$62.70M
GNFT annual free cash flow is -$62.70 million

Free cash flow 1-year change

+18.15%
GNFT annual free cash flow is up +18.15% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

98.81%
GNFT annual gross profit margin is 98.81%

Operating margin

-95.10%
GNFT annual operating profit margin is -95.10%

Net margin

-101.15%
GNFT annual net profit margin is -101.15%

ROA & ROE

ROA

-14.78%
GNFT annual return on assets is -14.78%

ROE

-35.45%
GNFT annual return on equity is -35.45%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GNFT price to earnings ratio value is unknown

PE ratio Sector rank

-
GNFT price to earnings ratio is unknown

PB Ratio

PB ratio

1.76
GNFT price to book ratio is 1.76

PB ratio Sector rank

59.34%
GNFT price to book ratio is higher than 59.34% of companies in Healthcare sector

PS Ratio

PS ratio

-
GNFT price to sales ratio value is unknown

PS ratio Sector rank

-
GNFT price to sales ratio is unknown

Enterprise value

Enterprise value

$190.51M
GNFT enterprise value is $190.51 million

Enterprise value Sector rank

58.73%
GNFT enterprise value is higher than 58.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GNFT EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
GNFT EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.94
GNFT annual current ratio is 2.94

Quick ratio

2.94
GNFT annual quick ratio is 2.94

Leverage

Debt to equity

0.95
GNFT annual debt to equity ratio is 0.95

Interest coverage ratio

-5.17
GNFT annual interest coverage ratio is -5.17

Risk & Stability

Piotroski F-Score

-
GNFT piotroski f-score value is unknown

Altman Z-Score

-1.97
GNFT altman z-score is -1.97

Analyst ratings

Recent major analysts updates

Feb 7, 25 HC Wainwright & Co.
Buy
Oct 11, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Jul 29, 24 HC Wainwright & Co.
Buy
Jun 11, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 5, 24 HC Wainwright & Co.
Buy
Dec 8, 23 HC Wainwright & Co.
Buy
Sep 21, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MDWD logo
MediWound (MDWD)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
CDXS logo
Codexis (CDXS)
ELDN logo
Eledon Pharmaceuticals (ELDN)
DRTS logo
Alpha Tau Medical (DRTS)
SOPH logo
SOPHiA GENETICS SA (SOPH)
DSGN logo
Design Therapeutics (DSGN)
TuHURA Biosciences (HURA)
GOSS logo
Gossamer Bio (GOSS)
  • What is the ticker symbol for Genfit SA?
  • Does Genfit SA pay dividends?
  • What sector is Genfit SA in?
  • What industry is Genfit SA in?
  • What country is Genfit SA based in?
  • When did Genfit SA go public?
  • Is Genfit SA in the S&P 500?
  • Is Genfit SA in the NASDAQ 100?
  • Is Genfit SA in the Dow Jones?
  • When was Genfit SA's last earnings report?
  • When does Genfit SA report earnings?

What is the ticker symbol for Genfit SA?

The ticker symbol for Genfit SA is NASDAQ:GNFT

Does Genfit SA pay dividends?

No, Genfit SA does not pay dividends

What sector is Genfit SA in?

Genfit SA is in the Healthcare sector

What industry is Genfit SA in?

Genfit SA is in the Biotechnology industry

What country is Genfit SA based in?

Genfit SA is headquartered in France

When did Genfit SA go public?

Genfit SA's initial public offering (IPO) was on March 27, 2019

Is Genfit SA in the S&P 500?

No, Genfit SA is not included in the S&P 500 index

Is Genfit SA in the NASDAQ 100?

No, Genfit SA is not included in the NASDAQ 100 index

Is Genfit SA in the Dow Jones?

No, Genfit SA is not included in the Dow Jones index

When was Genfit SA's last earnings report?

Genfit SA's most recent earnings report was on Sep 19, 2024

When does Genfit SA report earnings?

The next expected earnings date for Genfit SA is Apr 24, 2025
On this page